GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FSBW · Jun 30, 2025

FS Bancorp, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001437749-25-025677Bank
Sequential deposit growth15thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-2.36% · CORE · VALID

Net-income growth25thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-13.74% · CORE · VALID

Interest-income growth25thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

6.01% · CORE · VALID

Cash and equivalents30thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$33.2M · CORE · VALID

Sequential loan growth40thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

3.24% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History57 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
11.79%
Current
-2.36%
Delta
-14.15%
Earnings Growth Decreased
Previous
-4.48%
Current
-13.74%
Delta
-9.26%
Interest Income Growth Increased
Previous
4.25%
Current
6.01%
Delta
1.76%
Liquidity Decreased
Previous
$62.7M
Current
$33.2M
Delta
-$29.5M
Loan Growth Increased
Previous
-0.03%
Current
3.24%
Delta
3.28%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.